WELFORD CHART NOTES NEWSLETTER Volume 29, No. 5
Contents
1. Low severity color and choose a different color Low severity color 8 For Interactions High severity color click on the Prescriptions Color button 9 Click on a color that will stand out and then click Ox Make sure this color differs from the Interactions Low severity color It is fine to have it match the Alerts High severity color if you want it to sarah Quick Summary Medications Let s see how this works assuming you are using the Parser Quick r pokey Sum mary clarithromycin 1 Press Write New Note Note enter a patients name Te 2 For the note write The patient is on clarithromycin ranolazine and r sae atorvastatin Adar 3 Notice that the Lethal interaction between ranolazine and feat clarithromycin interrupts your work atorvastatin clarithromycin 4 Notice that the ranolazine clarithromycin interaction also appears in jj a the High Severity Color in the Parser Quick Summary Interactions m atorvastatin section while the less severe atorvastatin clarithromycin warning J lstthrempein appears in the Low Severity Color SEND US YOUR TIPS If you have tips shortcuts questions or suggestions for future newsletter topics please send them to us at Welford Medical Computing Inc or 3779 Hermitage Trail Rockford IL 61114 10 ranolazine MEDCOM Information Systems 2117 Stonington Avenue Hoffman Estates IL 60195 wcnsupport emir com2. Hew Indication since the drug is to be given flinnchoma concurrently with n a rheumatoid arthritis Intravenous Waldenstrom s macroglobulinemia immunoglobulin and the reference You might include other comments such as the fact that the study involved 11 patients with refractory pemphigus vulgaris involving at least 30 of body surface area etc 6 Check Off Label since this is not yet an FDA approved Indication 7 Click OK Comment Off Label Author User Note that this Indication is with intravenous immunoglobulin now on the list for rituximab You will Reference Ahmed AR Spiegelman Cavacini L et al Treatment of pemphigus vulgaris with ritusiniab no longer see a warning when you and intravenous immunoglobluin NEJM 20067355 1772 11779 prescribe rituximab for patients with pemphigus Notice that the Indications screen shows the Author as User instead of Program and that the DELETE button is available in case X Cancel Delete Hep you at some time want to delete this Indication PARSER QUICK SUMMARY ALERT AND INTERACTION ENHANCEMENTS User s Manual pgs 955 956 The Parser Quick Summary can generate many Drug Disease Alert and drug drug Interaction warnings Version 5 0 lets you choose two methods in order to make sure that you pay attention to the most dangerous of these warnings The methods are Interrupt the warning appears in a window on the screen interrupting your work in addit
3. WELFORD CHART NOTES NEWSLETTER Volume 29 No 5 November 2006 copyright 2006 Welford Medical Computing Inc All rights reserved EDIT YOUR INDICATIONS User s Manual pgs 950 952 The program comes with a database of indications for nearly every medication in the fe TESE Vocabulary System and warns if you are about to New Indication for RITUXIMAB start a patient on a medication for which there is no recognized indication These warnings help to Diaonosis pemphigus O 0 prevent you from ordering the wrong medication see the February 2006 Newsletten Comment with intravenous immunoglobulin f f However you may prescribe certain Reference Ahmed AR Spiegelman Cavacini L et al Treatment of medications for indications that are not listed in the pemphigus vulgaris with rituximab and intravenous inmunaglobluin program s database e g for certain off label uses a Rather than seeing these warnings unnecessarily you may prefer to add your own Indications to the list Let s give this a try Suppose you just read an article in a medical journal showing that rituximab is useful for treating pemphigus vulgaris FDA Approved Dft Label 1 Press Libraries Indications List 2 For Drug Name enter RITUXIMAB Cancel Help 3 Press NEw INDICATION 4 For Diagnosis type in M indications PEMPHIGUS Drug Hame RIT LSI MAR 5 For Comment type in with indications intravenous immunoglobulin age
4. ion to appearing on the Parser Quick Summary You are forced to click OK or CANCEL or press lt ESC gt to close the warning High severity color the warning appears on the Parser Quick Summary but in a different color from the warnings of a lower severity This makes them stand out so you can pay special attention to them To read the detailed explanation of the warning double click it You can combine these methods For example you EJ Parser Summary Options By default which of these do you want checked can arrange to have warnings of the highest severity interrupt Updates you AND appear in a different color in the Parser Quick dlleries Summary Lets set this up lv Diagnoses jw Lab Book 1 Press System Medication Options een 2 Set Interaction interrupt when to Major or above f Referal and press OK 3 Press System Global Options ee 4 Set aos Interrupt when to Major or above and heh ene oa press OK 5 Press System Parser Options SUMMARY OPTIONS T a e 6 For Alerts High severity color click on the Color Allergies button Brochures 7 Click on a color that will stand out for you such as Doses red then click Ok Note that the word Color next to Duplicate Class F i Formulary High severity color now appears in that color Make Indications sure this color differs from the Low severity color If f Interactions they are the same click on the Color button next to High severity color Color
Download Pdf Manuals
Related Search